2007
DOI: 10.1016/j.diabres.2006.08.004
|View full text |Cite
|
Sign up to set email alerts
|

Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

8
54
1
1

Year Published

2007
2007
2021
2021

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 76 publications
(64 citation statements)
references
References 36 publications
8
54
1
1
Order By: Relevance
“…In addition, it has been shown that serum LPLm concentrations are lower in conditions in which TG catabolism is disturbed, such as hypertriglyceridemia or increased remnant lipoproteins (Watanabe et al, 1999). Thus, serum LPLm concentration may be useful as a biomarker of metabolic syndrome (Saiki et al, 2007), despite the fact that circulating LPLm is enzymatically inactive. In this study, we found that the serum LPLm concentrations in neonates also had a significant inverse relationship with VLDL-TG concentrations, although their VLDL-TG concentrations were markedly lower than those in adults.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In addition, it has been shown that serum LPLm concentrations are lower in conditions in which TG catabolism is disturbed, such as hypertriglyceridemia or increased remnant lipoproteins (Watanabe et al, 1999). Thus, serum LPLm concentration may be useful as a biomarker of metabolic syndrome (Saiki et al, 2007), despite the fact that circulating LPLm is enzymatically inactive. In this study, we found that the serum LPLm concentrations in neonates also had a significant inverse relationship with VLDL-TG concentrations, although their VLDL-TG concentrations were markedly lower than those in adults.…”
Section: Discussionmentioning
confidence: 99%
“…Over the last decade, several studies showed that LPL mass in non-heparinized serum (LPLm) was a useful, physiologically relevant index of LPL-mediated lipolysis of plasma triacylglycerol (TG), because of low concentrations in LPL-deficient patients (Kern et al, 1990;Kobayashi et al, 1993) and significant relationships between serum LPLm, lipids, lipoproteins, and insulin resistance (Kobayashi et al, 1993(Kobayashi et al, , 2007Tornvall et al, 1995;Watanabe et al, 1999;Hanyu et al, 2007;Saiki et al, 2007). The aim of this study is to know the influence of LPL on neonatal subcutaneous fat growth.…”
Section: Introductionmentioning
confidence: 99%
“…Due to mutual action of catecholamines and glucocorticoids β 1 and β 2 receptors are stimulated in fat tissue, resulting in the increased lipolysis and vasodilatation in fat tissue which results in the increased concentration of free fatty acids from which cholesterol and triacylglycerols are synthesized. Catecholamines also inhibit the serum lipoprotein lipase activity (20) which under normal conditions breaks down triacylglycerols and very low density lipoproteins promoting the creation of high density lipoproteins (HDL cholesterol). When the activity of this enzyme is decreased, the concentration of triacylglycerols is increased and HDL choles- terol concetration is decreased.…”
Section: Discussionmentioning
confidence: 99%
“…More recently, Saiki et al [39] have reported that in 362 Japanese subjects with metabolic syndrome, the correlation coefficient between serum LPL mass and plasma adiponectin was high (r=0.562). They also have shown that both serum LPL mass and adiponectin correlated positively with HDL-C and inversely with body weight and TG.…”
Section: Serum Lpl Concentration and Serum Adiponectin Levelsmentioning
confidence: 99%